The publisher presents a series of issue reports which introduce the latest trends in the healthcare industry pinpointing key business issues. We have previously published issue reports on topics such as private medical insurance, electroceuticals, medical AI (Artificial Intelligence) and health screening and this issue report is intended to describe the current landscape of the market and forecast the future business potential of DTx (Digital Therapeutics), which has been recently at the center of attention.
In Korea, the market for digital therapeutic devices is still in its infancy. The first digital therapeutic device is not officially born until February 2023. However, there is a high potential for future growth, so we suggest that you draw the future of this market and utilize issue reports as a useful source of information on what direction to go.
Table of Contents
Terms and DefinitionsDisclaimer
Preface
1 Understanding Digital Therapeutics
1.1 Definition of DTx
1.2 Characteristics of Digital Therapeutics
1.3 Development History of Digital Therapeutics
1.4 Applications of Digital Therapeutics
1.5 Global Digital Therapeutics Market
2 DTx Market in Korea
2.1 Breakthrough Device Designation
2.2 Product Approval of MFDS
2.3 NHIS Listing and Coverage
2.3.1 Breakthrough Technology Designation
2.4 Clinical Trial Approval of MFDS
2.5 Current R&D in Korea
3 Major Suppliers of DTx in Korea
3.1 NUNAPS
3.2 DoBrain
3.3 LifeSemantics
3.4 S-Alpha Therapeutics
3.5 AIMMED
3.6 WELT
3.7 Other Suppliers
3.7.1 Neudive
3.7.2 Medimind (formerly known as F&I Korea)
3.7.3 Emocog
3.7.4 HAII
3.7.5 Huraypositive
4 Business Issues in DTx Market
4.1 Scope of DTx Classified as Medical Devices
4.2 Scope of Reimbursement DTx
4.3 Market Access Model of DTx in Korea
4.3.1 Target Conditions and Intended Uses
4.3.2 Clinical Grounds
4.3.3 Outlook for NHIS Coverage
4.3.4 Business Model Forecast
Companies Mentioned
- NUNAPS
- DoBrain
- LifeSemantics
- S-Alpha Therapeutics
- AIMMED
- WELT
- Neudive
- Medimind
- Emocog
- HAII
- Huraypositive
- NeuroEars
- Neopons
- DIGITAL PHARM
- MINDsAI
- Tech Village
Methodology
LOADING...
